Medline Inc Ordinary Shares - Class A L10
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €31.40
- Day Range
- €31.60–31.60
- 52-Week Range
- €27.40–42.60
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 877.35M
- Market Cap
- €27.72B
- Volume/Avg
- — / 35
Key Statistics
- Price/Earnings (Normalized)
- 77.29
- Price/Sales
- 1.64
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 45,000
- Website
- https://www.medline.com
Competitors
Valuation
|
Metric
|
L10
|
CAH
|
MCK
|
|---|---|---|---|
Price/Earnings (Normalized) | 77.29 | 21.10 | 23.00 |
Price/Book Value | 2.73 | — | — |
Price/Sales | 1.64 | 0.22 | 0.28 |
Price/Cash Flow | 18.95 | 16.03 | 18.69 |
Price/Earnings
L10
CAH
MCK
Financial Strength
|
Metric
|
L10
|
CAH
|
MCK
|
|---|---|---|---|
Quick Ratio | 2.34 | 0.43 | 0.50 |
Current Ratio | 4.33 | 0.88 | 0.89 |
Interest Coverage | 2.40 | 7.25 | 23.83 |
Quick Ratio
L10
CAH
MCK
Profitability
|
Metric
|
L10
|
CAH
|
MCK
|
|---|---|---|---|
Return on Assets (Normalized) | 2.60% | 4.62% | 5.95% |
Return on Equity (Normalized) | 14.71% | — | — |
Return on Invested Capital (Normalized) | 4.62% | 46.33% | 56.43% |
Return on Assets
L10
CAH
MCK
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|^W<&Ms>b | LOCK|H#^ | $150B | |||
| Becton Dickinson & Co
BDX
| LOCK|X> | LOCK|C!$#% | $50B | |||
| ResMed Inc
RMD
| LOCK|Wx!QR#t | LOCK|fzT? | $32B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|#mmQ?? | LOCK|T^Fg | $32B | |||
| Alcon Inc
ALC
| LOCK|cC!sTtd | LOCK|Xd^Q | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|?&g<$Y? | LOCK|#ws | $26B | |||
| Solventum Corp
SOLV
| LOCK|v^>Q#pF | LOCK|^> | $15B | |||
| Baxter International Inc
BAX
| LOCK|s<& | LOCK|H$R&$ | $13B | |||
| Repligen Corp
RGEN
| LOCK|@FvlN&c | LOCK|kHY## | $11B | |||
| The Cooper Companies Inc
COO
| LOCK|Kb>#jp | LOCK|CLnPP | $10B |
United States